+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Surface Markers Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Cell Surface Markers Market by Product Type, Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Cell Surface Markers Market by Product Type, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010769
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cell surface markers market is experiencing significant transformation driven by technological innovation and global shifts in supply chain dynamics. Across the healthcare and life sciences landscape, these markers have emerged as critical assets in guiding research, diagnostics, and therapeutic development for senior decision-makers focused on futureproofing strategy.

Cell Surface Markers Market Snapshot

The global cell surface markers market expanded from USD 858.27 million in 2024 to USD 939.88 million in 2025 and is projected to reach USD 1.46 billion by 2030, registering a CAGR of 9.34%. This robust growth reflects persistent demand for advanced immunophenotyping, increased adoption in precision medicine, and integration of high-throughput cytometry technologies. Market momentum is further amplified by innovation in assay design and evolving healthcare workflows, positioning cell surface markers as integral to both clinical and research-focused applications.

Scope & Segmentation of the Cell Surface Markers Market

  • Product Types: Monoclonal antibodies (including IgA, IgG, IgM), polyclonal antibodies from goat, mouse, and rabbit sources, complementary reagents, and lectins offer a comprehensive toolkit for end users across research and diagnostics.
  • Technology Platforms: The market leverages enzyme-linked immunosorbent assays, conventional and imaging flow cytometry, mass cytometry, immunocytochemistry, and immunohistochemistry, supporting detailed marker analysis at both cellular and tissue levels.
  • Key Applications: Diagnostics span cardiovascular, oncology, and infectious disease panels. Research applications focus on cancer, immunology, and stem cell investigations, while therapeutic uses support autoimmune and cancer immunotherapy development.
  • End Users: Academic research institutes, contract research organizations, hospitals and diagnostic laboratories, and pharmaceutical and biotechnology companies each drive adoption aligned with their unique operational priorities.
  • Regional Coverage: Americas (including major U.S. states such as California, Texas, and Illinois, plus Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (featuring key countries such as United Kingdom, France, Saudi Arabia, South Africa, and more), and Asia-Pacific (China, India, Japan, Australia, and additional markets) demonstrate distinctive demand patterns and growth strategies.
  • Company Analysis: The report includes significant market developments and trends from leading firms such as Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, Bio-Techne Corporation, Abcam plc, PerkinElmer, Agilent Technologies, and Sartorius AG.

Key Takeaways for Senior Decision-Makers

  • The cell surface markers market is being reshaped by the proliferation of advanced cytometry instruments, multiplexed immunoassays, and data analytics, enhancing both workflow efficiency and assay depth.
  • Growing convergence between technology providers, reagent manufacturers, and software developers is fueling end-to-end solution integration and accelerating go-to-market timelines.
  • Strategic collaboration, regionalized manufacturing, and investment in training infrastructure are emerging as pivotal approaches to sustain competitive edge, particularly in high-growth Asia-Pacific environments.
  • Diagnostics and personalized medicine applications are expanding rapidly as healthcare stakeholders increasingly focus on precision monitoring and patient stratification powered by cell surface marker insights.
  • Companies offering value-added services such as assay validation, technical support, and digital analytics portals are achieving greater market presence by aligning with end-user needs.

Tariff Impact: Navigating Recent U.S. Policy Shifts

The implementation of new U.S. tariffs in 2025 has increased production costs for reagents and instrumentation reliant on imported materials. In response, industry leaders are pivoting sourcing strategies, accelerating domestic production, and negotiating long-term supplier contracts. These measures are essential to maintain supply continuity and cost control, but they also drive renewed focus on risk mitigation, supply chain flexibility, and collaborative procurement planning among research and clinical institutions.

Methodology & Data Sources

This report’s analysis leverages a blend of primary and secondary research. Primary inputs include interviews with market executives, researchers, and procurement professionals. Quantitative surveys address adoption, budget, and technology trends. Secondary research validates insights using peer-reviewed literature, regulatory filings, and financial disclosures, ensuring a robust foundation for forecasting and benchmarking.

Why This Report Matters

  • This report enables decision-makers to identify actionable market opportunities, aligning investment strategies with the most dynamic product and technology segments in the cell surface markers market.
  • Coverage spans the full competitive landscape, empowering stakeholders to benchmark against leading suppliers and anticipate the impact of policy and regional market shifts.
  • Strategically segmented insights support prioritization of expansion efforts by region or application, optimizing resource allocation for sustainable growth.

Conclusion

The cell surface markers market is advancing through innovation, targeted partnerships, and adaptive supply chain strategies. In-depth analysis and actionable segmentation equip stakeholders with the intelligence required to thrive in this evolving sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cell Surface Markers Market, by Product Type
8.1. Introduction
8.2. Complementary Reagents
8.3. Lectins
8.4. Monoclonal Antibodies
8.4.1. IgA
8.4.2. IgG
8.4.3. IgM
8.5. Polyclonal Antibodies
8.5.1. Goat
8.5.2. Mouse
8.5.3. Rabbit
9. Cell Surface Markers Market, by Technology
9.1. Introduction
9.2. Enzyme Linked Immunosorbent Assay
9.3. Flow Cytometry
9.3.1. Conventional Flow Cytometry
9.3.2. Imaging Flow Cytometry
9.3.3. Mass Cytometry
9.4. Immunocytochemistry
9.5. Immunohistochemistry
10. Cell Surface Markers Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Cardiovascular Diagnostics
10.2.2. Infectious Disease Diagnostics
10.2.3. Oncology Diagnostics
10.3. Research
10.3.1. Cancer Research
10.3.2. Immunology Research
10.3.3. Stem Cell Research
10.4. Therapeutics
10.4.1. Autoimmune Disease Therapeutics
10.4.2. Cancer Therapeutics
11. Cell Surface Markers Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals And Diagnostic Laboratories
11.5. Pharmaceutical And Biotechnology Companies
12. Americas Cell Surface Markers Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cell Surface Markers Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cell Surface Markers Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Becton, Dickinson and Company
15.3.4. Danaher Corporation
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Bio-Techne Corporation
15.3.7. Abcam plc
15.3.8. PerkinElmer, Inc.
15.3.9. Agilent Technologies, Inc.
15.3.10. Sartorius AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CELL SURFACE MARKERS MARKET MULTI-CURRENCY
FIGURE 2. CELL SURFACE MARKERS MARKET MULTI-LANGUAGE
FIGURE 3. CELL SURFACE MARKERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CELL SURFACE MARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CELL SURFACE MARKERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CELL SURFACE MARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CELL SURFACE MARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY COMPLEMENTARY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY LECTINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY GOAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MOUSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RABBIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOCYTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CARDIOVASCULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY IMMUNOLOGY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY AUTOIMMUNE DISEASE THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CANCER THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CELL SURFACE MARKERS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES CELL SURFACE MARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 70. CANADA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. CANADA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 72. CANADA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 73. CANADA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. CANADA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 75. CANADA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. CANADA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 77. CANADA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 78. CANADA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 79. CANADA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CELL SURFACE MARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 133. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 136. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 138. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 139. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 140. GERMANY CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 143. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. ITALY CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 163. ITALY CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 164. ITALY CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. ITALY CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 166. ITALY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. ITALY CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 168. ITALY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 169. ITALY CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 170. ITALY CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 173. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 174. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 176. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 178. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 179. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 180. SPAIN CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 213. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 214. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 216. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 218. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 219. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 220. DENMARK CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. QATAR CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. QATAR CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 233. QATAR CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 234. QATAR CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. QATAR CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 236. QATAR CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. QATAR CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 238. QATAR CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 239. QATAR CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 240. QATAR CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 243. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 244. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 246. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 248. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 249. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 250. FINLAND CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 273. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 274. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 276. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 278. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 279. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 280. EGYPT CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 283. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 284. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 285. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 286. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 288. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 289. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 290. TURKEY CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 303. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 304. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 306. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 308. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 309. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 310. NORWAY CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. POLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. POLAND CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 313. POLAND CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 314. POLAND CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. POLAND CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 316. POLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. POLAND CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 318. POLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 319. POLAND CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 320. POLAND CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 328. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 329. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 330. SWITZERLAND CELL SURFACE MARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY POLYCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC CELL SURFACE MARKERS MARKET SIZE, BY DIAGNOSTICS, 2018-20

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cell Surface Markers market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Abcam plc
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Sartorius AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 939.88 Million
Forecasted Market Value ( USD ) by 2030 $ 1460 Million
Compound Annual Growth Rate9.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cell Surface Markers - Global Strategic Business Report - Product Image

Cell Surface Markers - Global Strategic Business Report

  • Report
  • 683 Pages
  • Global
From
Cell Surface Markers Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cell Surface Markers Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cell Surface Markers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Global Cell Surface Markers Detection - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Cell Surface Markers Detection - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 114 Pages
  • Global
From
Cell Surface Marker Detection Market Report 2025 - Product Image

Cell Surface Marker Detection Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Market

Cell surface markers are a type of biomarker used to identify and characterize cells. They are proteins found on the surface of cells that can be used to distinguish between different types of cells, such as healthy and diseased cells. Cell surface markers can be used to diagnose diseases, monitor disease progression, and evaluate the effectiveness of treatments. They can also be used to study the development and function of cells in the body. Cell surface markers are used in a variety of research and clinical applications, including cancer diagnostics, immunology, stem cell research, and drug development. Companies in the cell surface marker market include Bio-Rad Laboratories, Merck KGaA, Thermo Fisher Scientific, Becton Dickinson, and Agilent Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.